qa_id stringlengths 27 27 | qa_group_id stringlengths 28 32 | qa_family stringclasses 3
values | subtask_type stringclasses 7
values | qa_subtype stringclasses 3
values | cluster_id stringclasses 42
values | language stringclasses 1
value | split stringclasses 1
value | question stringlengths 148 1.41k | answer stringlengths 718 10.8k | claim_ids listlengths 0 8 | paper_ids listlengths 1 5 | evidence_span_ids listlengths 0 7 | association_ids listlengths 0 4 | hypothesis_ids listlengths 0 4 | record_json stringlengths 4.37k 33.7k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QA:021b176e07eeb7b171a0a5fd | QAG:d6db33b422f7b28acdd87541 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Method We used quantitative real-time polymerase chain reaction (qRT-PCR) to measure the expression levels of five target genes in a cohort of 49 patients (33 with gastric cancer and 16 with urothelial carcinoma) who had received immunotherapy and whose therapeutic res... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2d2c32f7f3149c89060ba46b","quotes":["Method We used quantitative real-time polymerase chain reaction (qRT-PCR) to... | [
"CLM:2d2c32f7f3149c89060ba46b",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMID:36455365"
] | [
"SPAN:3b1a55ff956bc24dd8b9188f"
] | [] | [] | {"qa_id":"QA:021b176e07eeb7b171a0a5fd","qa_group_id":"QAG:d6db33b422f7b28acdd87541","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Method We used quantitative real-time polymerase chain reaction (q... |
QA:03cc77b0c35fcc3fee44eb2f | QAG:7b5efbb2e9fe442d905bf1f7 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The EVIDENCE study aims to evaluate the efficacy, safety, treatment model, and clinical outcomes of trastuzumab in Chinese HER2‐positive metastatic gastric cancer patients"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated proven... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:675f244069e66ee9c0e60fb2","quotes":["The EVIDENCE study was designed to evaluate the efficacy, safety, treatment ... | [
"CLM:675f244069e66ee9c0e60fb2",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:b6ecd12976df5a828bb095cc"
] | [] | [] | {"qa_id":"QA:03cc77b0c35fcc3fee44eb2f","qa_group_id":"QAG:7b5efbb2e9fe442d905bf1f7","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The EVIDENCE study aims to evaluate the efficacy, safety, treatmen... |
QA:07111534d1fa3e5527878c22 | QAG:f8894f8b89cde706f059dab8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Table 1 Baseline characteristics of the patients with gastric carcinoma received ICB therapy Characteristics EBV+/pMMR (n=22) EBV−/pMMR (n=44) EBV−/dMMR (n=29) P value: EBV+/pMMR versus EBV−/pMMR P value: EBV+/pMMR versus EBV−/dMMR Age Median (range) 63.5 (28–74) 59.0 ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:de6383b1f7f2f6d7129a8592","quotes":["Table 1 Baseline character... | [
"CLM:de6383b1f7f2f6d7129a8592",
"CLM:06d7a8039e910d5ad18fe47c",
"CLM:00345af022967e4fba38c511",
"CLM:5dc13771e118450bc11e8e2b"
] | [
"PMCID:PMC8896035",
"PMCID:PMC7082319",
"PMCID:PMC8994342"
] | [
"SPAN:fcb2d2b3a07b3111d1181c74",
"SPAN:fa9a5f716ba02975b6d21b57",
"SPAN:b515737f753163aadabf6f12"
] | [
"ASC2:3137f8ca7c2cda360386179a",
"ASC2:83405feae9c5326e5a00e5a5"
] | [
"HYP:DCH:1a3bf3566008721807aa2be6",
"HYP:DCH:a075ded8967bc461dd6538a1"
] | {"qa_id":"QA:07111534d1fa3e5527878c22","qa_group_id":"QAG:f8894f8b89cde706f059dab8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Table 1 Baseline characteristics of the patients with gastric carc... |
QA:076026e7b8fe082a2e3c8e92 | QAG:763fdc9542c2375408e5696e | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The patient was diagnosed with stage IV gastric cancer with direct invasion to liver ( Figure 7 a,b) and received capecitabine + oxaliplatin + pembrolizumab"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requiremen... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:29929d998242dd0505ee56ca","quotes":["The patient was diagnosed with stage IV gastric cancer with direct invasion ... | [
"CLM:29929d998242dd0505ee56ca",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10669208"
] | [
"SPAN:20be1c9636dcbb95b1fa8a3a"
] | [] | [] | {"qa_id":"QA:076026e7b8fe082a2e3c8e92","qa_group_id":"QAG:763fdc9542c2375408e5696e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The patient was diagnosed with stage IV gastric cancer with direct... |
QA:07dfc8b91f10da25dc3cb030 | QAG:fa7659ba3f97f6067f912226 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "All four patients with liver metastasis from colon cancer achieved CR, including three with pCR and one with cCR. pCR was achieved in two of five patients with non-liver metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span ref... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3f990a8ef9a80e7c0222843b","quotes":["All four patients with liver metastasis from colon cancer reached CR, includ... | [
"CLM:3f990a8ef9a80e7c0222843b",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:a902225e40d4acdcaf399e04"
] | [] | [] | {"qa_id":"QA:07dfc8b91f10da25dc3cb030","qa_group_id":"QAG:fa7659ba3f97f6067f912226","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"All four patients with liver metastasis from colon cancer achieved... |
QA:095113b8110dcb51acde3169 | QAG:7ce10a9aaac4a241ad232136 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "2‐positive gastric cancer patients who had failed standard treatment received Chimeric antigen receptor (CAR)‐T cell therapy and achieved an ORR of 57.1%"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements:... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e380341c51871d808b2aea0a","quotes":["In a phase I study initiated by researchers, 28 Claudin18.2‐positive gastric... | [
"CLM:e380341c51871d808b2aea0a",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:09975a8fd318610f6c22bd8d"
] | [] | [] | {"qa_id":"QA:095113b8110dcb51acde3169","qa_group_id":"QAG:7ce10a9aaac4a241ad232136","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"2‐positive gastric cancer patients who had failed standard treatme... |
QA:0a4caf4ed264b81648b83419 | QAG:ee80909b4416b63d4e1439e2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The phase II multicenter C008 study showed that Disitamab vedotin used in advanced gastric cancer patients with HER2 positive expression (IHC 2+ or 3+) who had previously received ≥2 lines of therapy achieved an ORR of 24.4% and a median OS of 7.6 months"? Return the o... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:27ea3d10c98e2269c7be479d","quotes":["The phase II multicenter C008 study showed that Disitamab vedotin used in ad... | [
"CLM:27ea3d10c98e2269c7be479d",
"CLM:06d7a8039e910d5ad18fe47c"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:5231bf8330376182bcfded83"
] | [] | [] | {"qa_id":"QA:0a4caf4ed264b81648b83419","qa_group_id":"QAG:ee80909b4416b63d4e1439e2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The phase II multicenter C008 study showed that Disitamab vedotin ... |
QA:0c2638c741667bdc89ada4ea | QAG:8d47c3d15625e4b031334481 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "We aimed to assess whether TMB was associated with the response to immunotherapy and to examine its relation with other biomarkers of immunotherapy response in advanced gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0f10aec3cfff637781303dd8","quotes":["We aimed to assess whether TMB is associated with t... | [
"CLM:0f10aec3cfff637781303dd8",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:08443da1793a00c9b7f19a98"
] | [
"PMCID:PMC7082319",
"PMCID:PMC6712454"
] | [
"SPAN:f143174205fb4f358ec8245d",
"SPAN:d488427d3d218addc147001d"
] | [
"ASC2:7e019eca2c41ceb64e4f2a6d"
] | [
"HYP:DCH:4635220242a709ff7e73a126"
] | {"qa_id":"QA:0c2638c741667bdc89ada4ea","qa_group_id":"QAG:8d47c3d15625e4b031334481","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"We aimed to assess whether TMB was associated with the response to... |
QA:0deffde678cc090bb7390e5d | QAG:5ed20d81628c9bcbc478745f | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Similarly, in the post-hoc analysis of the KEYNOTE-061 phase III study, pembrolizumab improved OS compared with paclitaxel as 2 nd -line therapy in patients with PD-L1 positive (CPS ≥ 10%) advanced gastric cancer, whereas PFS and OS curves between pembrolizumab and pac... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:5dc13771e118450bc11e8e2b","quotes":["Similarly, in the post-hoc... | [
"CLM:5dc13771e118450bc11e8e2b",
"CLM:030dc49284f8a34331af4784",
"CLM:00345af022967e4fba38c511",
"CLM:de6383b1f7f2f6d7129a8592",
"CLM:88bd2f3a71633f2c589dee1e"
] | [
"PMCID:PMC8994342",
"PMCID:PMC7082319",
"PMCID:PMC8896035",
"PMCID:PMC10160363"
] | [
"SPAN:b515737f753163aadabf6f12",
"SPAN:fa9a5f716ba02975b6d21b57",
"SPAN:fcb2d2b3a07b3111d1181c74",
"SPAN:555320ad60e9f047d76bf14f"
] | [
"ASC2:3137f8ca7c2cda360386179a",
"ASC2:83405feae9c5326e5a00e5a5",
"ASC2:fcc86b8f447cf15e498bfa4d"
] | [
"HYP:DCH:d78814b24dbb5c2bc0da0f12",
"HYP:DCH:651b660371e51b26487e49af"
] | {"qa_id":"QA:0deffde678cc090bb7390e5d","qa_group_id":"QAG:5ed20d81628c9bcbc478745f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Similarly, in the post-hoc analysis of the KEYNOTE-061 phase III s... |
QA:0ec7124c1de87e03d824c938 | QAG:6c5e1859a112c31aca98ede8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In our cohort three patients with locally advanced gastric cancer achieved pCR"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b702b1721ece7528a0692ded","quotes":["In our cohort three patients with locally advanced gastric cancer achieved p... | [
"CLM:b702b1721ece7528a0692ded",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:de142d3dbbdf8b8fc024d8a5"
] | [] | [] | {"qa_id":"QA:0ec7124c1de87e03d824c938","qa_group_id":"QAG:6c5e1859a112c31aca98ede8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In our cohort three patients with locally advanced gastric cancer ... |
QA:1552cd1a8e3f94ff3333b60c | QAG:3124dbbdcce7a4225c83f479 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Results of the international multicenter CRITICS study showed that compared with adjuvant chemotherapy alone, adjuvant chemoradiotherapy did not improve survival for stage IB‐IVA resectable gastric cancer or EGJ cancer patients who received neoadjuvant epirubicin, cisp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:4fe00906ece671c162963cdb","quotes":["Results of the international multicenter CRITICS study [ 106 ] showed that c... | [
"CLM:4fe00906ece671c162963cdb",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:844a23ae9d1acd29f5c3b6d1"
] | [] | [] | {"qa_id":"QA:1552cd1a8e3f94ff3333b60c","qa_group_id":"QAG:3124dbbdcce7a4225c83f479","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Results of the international multicenter CRITICS study showed that... |
QA:1c35ffe557b527d1df999268 | QAG:ef4dfafb5c9f1f6a533ddfdd | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Patients who have undergone chemotherapy may have decreased tolerance to radiotherapy, and strategies to enhance tolerability, such as acid suppression, nutritional support, dose reduction or consideration of single‐agent fluoropyrimidine‐based chemotherapy regimens du... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3b65609cd271baa878840b61","quotes":["Patients who have undergone chemotherapy may have reduced tolerance to radio... | [
"CLM:3b65609cd271baa878840b61",
"CLM:030dc49284f8a34331af4784"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:93f7db4f3c7b57f1dd7a4e3c"
] | [] | [] | {"qa_id":"QA:1c35ffe557b527d1df999268","qa_group_id":"QAG:ef4dfafb5c9f1f6a533ddfdd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Patients who have undergone chemotherapy may have decreased tolera... |
QA:1c88c22d483782f14021d552 | QAG:d92c9be0973b3a2b42dc976d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Methods A total of 192 gastric cancer (GC) patients were enrolled in this cohort"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8218d73eecf48551039837f2","quotes":["Methods A total of 192 gastric cancer (GC) patients were enrolled in this co... | [
"CLM:8218d73eecf48551039837f2",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC8107625"
] | [
"SPAN:d5327f12cc717383bf0a6d16"
] | [] | [] | {"qa_id":"QA:1c88c22d483782f14021d552","qa_group_id":"QAG:d92c9be0973b3a2b42dc976d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Methods A total of 192 gastric cancer (GC) patients were enrolled ... |
QA:20bb2636b2e8db66ea86815c | QAG:67aca7a13bdd813a059f85d8 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9652899? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9652899","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9652899"
] | [] | [] | [] | {"qa_id":"QA:20bb2636b2e8db66ea86815c","qa_group_id":"QAG:67aca7a13bdd813a059f85d8","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9652899... |
QA:244cc02d7ff68cc9a36017a5 | QAG:4bc99ddc34cb31fdf8875881 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8268941? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC8268941","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC8268941"
] | [] | [] | [] | {"qa_id":"QA:244cc02d7ff68cc9a36017a5","qa_group_id":"QAG:4bc99ddc34cb31fdf8875881","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8268941... |
QA:277edd0c6d6e626e923a0920 | QAG:98028805471b4e7d63d845ef | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "7 months for 1206 stage IV gastric cancer patients who received conversion surgery"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Sp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:46461a52604b9fc7372451da","quotes":["More recently, a retrospective Asian cohort study (CONVO-GC-1) reported medi... | [
"CLM:46461a52604b9fc7372451da",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10669208"
] | [
"SPAN:7eaecf4bcda33c3c58944b82"
] | [] | [] | {"qa_id":"QA:277edd0c6d6e626e923a0920","qa_group_id":"QAG:98028805471b4e7d63d845ef","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"7 months for 1206 stage IV gastric cancer patients who received co... |
QA:2c9865be272fc542953a08b2 | QAG:3dd1a133f7c857fca2a4120e | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "All four patients with liver metastatic lesions from colon cancer achieved CR. pCR was achieved in two of five patients with non-liver metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance req... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:53bdae71a41719178f8f816b","quotes":["All four patients with liver metastatic lesions from colon cancer reached CR... | [
"CLM:53bdae71a41719178f8f816b",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:68446dc2c8ab44a32529d5cf"
] | [] | [] | {"qa_id":"QA:2c9865be272fc542953a08b2","qa_group_id":"QAG:3dd1a133f7c857fca2a4120e","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"All four patients with liver metastatic lesions from colon cancer ... |
QA:2f0c1d7bdbd1c70072dd502c | QAG:950183b02bafa98716d1823b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Recent clinical study in advanced gastric cancer patients investigating the safety and efficacy of toriparimab, a newly approved humanized PD-1 antibody, showed that high TMB (12 mt/mb, upper 20 percentile cut-off) was associated with improved patient responses and sur... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e49fa7ed81184fc679bd847f","quotes":["Recent clinical study in advanced gastric cancer pa... | [
"CLM:e49fa7ed81184fc679bd847f",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:6619ca97e51076bae9dd521f"
] | [
"PMCID:PMC7082319",
"PMCID:PMC8491424"
] | [
"SPAN:8a1076f3de5e40d2c863ee43",
"SPAN:f3ffb145836ffa63e7412004"
] | [
"ASC2:24eff0751e7180788c5c42c9"
] | [
"HYP:DCH:12afce861c9db0c3321e841f"
] | {"qa_id":"QA:2f0c1d7bdbd1c70072dd502c","qa_group_id":"QAG:950183b02bafa98716d1823b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Recent clinical study in advanced gastric cancer patients investig... |
QA:2f168df088bbc8da728c35ea | QAG:a1477af341b802b6a230b7bf | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "all of whom achieved cCR and avoided surgical treatment"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess the e... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ad58a395ae7ddaab86664a20","quotes":["Cercek et al [ 28 ] reported 14 patients with dMMR/MSI-H rectal cancer using... | [
"CLM:ad58a395ae7ddaab86664a20",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:b4b8911852a4f3c512b0f8e1"
] | [] | [] | {"qa_id":"QA:2f168df088bbc8da728c35ea","qa_group_id":"QAG:a1477af341b802b6a230b7bf","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"all of whom achieved cCR and avoided surgical treatment\"? Return ... |
QA:32595f3bf8e1496e0991d910 | QAG:c07f4b25b6396fa008eb9c6d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "all of whom had some tumor pathological response after emergency surgery, including one who achieved pCR and three with pathological ratings of TRG2–3. We also observed five patients with regional lymph node enlargement during treatment"? Return the original wording wi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:cbc6a6f625f494f55b068808","quotes":["Our cohort reported four patients with MSI-H colon cancer with obstruction a... | [
"CLM:cbc6a6f625f494f55b068808",
"CLM:030dc49284f8a34331af4784"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:765c5514bd7a446093aca70d"
] | [] | [] | {"qa_id":"QA:32595f3bf8e1496e0991d910","qa_group_id":"QAG:c07f4b25b6396fa008eb9c6d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"all of whom had some tumor pathological response after emergency s... |
QA:3331e6c32612e75dff2ac94b | QAG:5cd16fe8b8ba6e593f7c87de | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "CR was achieved in four of five patients with low rectal cancer, including three with cCR and one with pCR"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:e6716bcd1b56d80db4c9b849","quotes":["CR was achieved in four of five patients with low rectal cancer, including t... | [
"CLM:e6716bcd1b56d80db4c9b849",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:b9053858d26a906fac199213"
] | [] | [] | {"qa_id":"QA:3331e6c32612e75dff2ac94b","qa_group_id":"QAG:5cd16fe8b8ba6e593f7c87de","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"CR was achieved in four of five patients with low rectal cancer, i... |
QA:34758d2925636fc838d8761a | QAG:15750fe4e411f89ba34449cd | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "A series of studies on advanced or metastatic dMMR/MSI-h gastrointestinal malignancies such as gastric and colorectal cancer showed that PD1 blockade achieved better therapeutic effects"? Return the original wording with paper, Claim, and Evidence Span references.
Int... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:029b26bc41b64f28748169a4","quotes":["A series of studies[ 15 - 18 ] on advanced or metas... | [
"CLM:029b26bc41b64f28748169a4",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:3f001575dc5ba7f2bd6df54b",
"CLM:f36d986959e3872159f9bc87",
"CLM:91ed29d5543c0e4194721a87"
] | [
"PMCID:PMC9988634",
"PMCID:PMC10255232",
"PMCID:PMC8201030"
] | [
"SPAN:3c3ff17dabcadb323a410fec",
"SPAN:0b5ffb2bc4afa0d76766e287",
"SPAN:0e6be7c879db295a68821686",
"SPAN:cbc28044869692d9c2bb8065"
] | [
"ASC2:ffc05108ea43a984af809178",
"ASC2:f2d915a118e77a5c47822bd2"
] | [
"HYP:DCH:5b3d92c92293d98579b0ea3f"
] | {"qa_id":"QA:34758d2925636fc838d8761a","qa_group_id":"QAG:15750fe4e411f89ba34449cd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"A series of studies on advanced or metastatic dMMR/MSI-h gastroint... |
QA:38942107cc4a95977ddc2484 | QAG:5b166f57e6c893a45898f153 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Another phase II trial combining ICI and concurrent chemoradiotherapy achieved excellent rates of R0 resection (95.0%), MPR (73.7%), and CPR (42.1%) in localized advanced gastric cancer, 17.9% of which were T4bN+, with no molecular pathology reported 36"? Return the or... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c5b24339efe6dae28e38873c","quotes":["Another phase II trial combining ICI and concurrent chemoradiotherapy achiev... | [
"CLM:c5b24339efe6dae28e38873c",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9810618"
] | [
"SPAN:9ff57cdbd9e9213cd400609d"
] | [] | [] | {"qa_id":"QA:38942107cc4a95977ddc2484","qa_group_id":"QAG:5b166f57e6c893a45898f153","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Another phase II trial combining ICI and concurrent chemoradiother... |
QA:39f12b2720e254e1fa5b10cd | QAG:8c424d2707d13e56feee36f4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Wang et al found that combination of AKT1 and CDH1 mutations predicted primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return t... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9bb8dff244c5c2a3be95ea2f","quotes":["Wang et al [ 41 ] found that combination of AKT1 and CDH1 mutations predicte... | [
"CLM:9bb8dff244c5c2a3be95ea2f",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:57c7bd2dac43372ba1043676"
] | [] | [] | {"qa_id":"QA:39f12b2720e254e1fa5b10cd","qa_group_id":"QAG:8c424d2707d13e56feee36f4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Wang et al found that combination of AKT1 and CDH1 mutations predi... |
QA:3a6cf51d75659ebea2e82917 | QAG:0724226ba0a662cdd75d246a | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Three patients with locally advanced gastric cancer achieved pathological CR (pCR)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Sp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c23e7c7f0338ee9b79cb87f2","quotes":["Three patients with locally advanced gastric cancer achieved pathological CR... | [
"CLM:c23e7c7f0338ee9b79cb87f2",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:b592dcd52720e0ac53ee21fc"
] | [] | [] | {"qa_id":"QA:3a6cf51d75659ebea2e82917","qa_group_id":"QAG:0724226ba0a662cdd75d246a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Three patients with locally advanced gastric cancer achieved patho... |
QA:3ab3627e3b76d602891b567e | QAG:aded50039fe3374e88b29350 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35065582? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable an... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMID:35065582","verdict":"no_released_traceable_claim","reason":"No Cla... | [] | [
"PMID:35065582"
] | [] | [] | [] | {"qa_id":"QA:3ab3627e3b76d602891b567e","qa_group_id":"QAG:aded50039fe3374e88b29350","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMID:35065582? E... |
QA:3abca5725f0530845829f92e | QAG:dc03634eddde134d83b97fbb | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "To further evaluate response predictors, response to ICB was correlated with gastric cancer molecular subtypes ( 11 )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:08627091714cf40204cec2a0","quotes":["To further evaluate response predictors, response to ICB was correlated with... | [
"CLM:08627091714cf40204cec2a0",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:b521be2efe0676867c8b8102"
] | [] | [] | {"qa_id":"QA:3abca5725f0530845829f92e","qa_group_id":"QAG:dc03634eddde134d83b97fbb","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"To further evaluate response predictors, response to ICB was corre... |
QA:3b76fe6fe5eacfa8743738f4 | QAG:ee5f72fbc4362a7983c3b233 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Finally, 63 patients with metastatic gastric cancer were included in the study"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6b42554b4e1ac46266c1b29d","quotes":["Finally, 63 patients with metastatic gastric cancer were included in the stu... | [
"CLM:6b42554b4e1ac46266c1b29d",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:a5a57bcda3dbb4d1a3d9d02a"
] | [] | [] | {"qa_id":"QA:3b76fe6fe5eacfa8743738f4","qa_group_id":"QAG:ee5f72fbc4362a7983c3b233","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Finally, 63 patients with metastatic gastric cancer were included ... |
QA:3cbebb002136b5beb22783cf | QAG:0234f8ca0d1d829a1f72993f | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Summary Background Response to immunotherapy in gastric cancer was associated with microsatellite instability (or mismatch repair deficiency) and Epstein-Barr virus (EBV) positivity"? Return the original wording with paper, Claim, and Evidence Span references.
Integra... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7a4fa8f51e342438146a0656","quotes":["Summary Background Response to immunotherapy in gastric cancer is associated... | [
"CLM:7a4fa8f51e342438146a0656",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC8460994"
] | [
"SPAN:bb951f8a374d97ff0633e00d"
] | [] | [] | {"qa_id":"QA:3cbebb002136b5beb22783cf","qa_group_id":"QAG:0234f8ca0d1d829a1f72993f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Summary Background Response to immunotherapy in gastric cancer was... |
QA:3da104ee32da14312d671a2d | QAG:5c1d426507aab60c9e2b31da | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7815473? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC7815473","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC7815473"
] | [] | [] | [] | {"qa_id":"QA:3da104ee32da14312d671a2d","qa_group_id":"QAG:5c1d426507aab60c9e2b31da","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC7815473... |
QA:41259555d7c9e6836c483d8d | QAG:3b4e408257f7ac57cc1352c4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "PD-1 and PD-L1 co-expression predicted favorable prognosis in gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span ref... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:61b8310d091047cb03df8318","quotes":["2015;35(10):5369–5376. 8. ... | [
"CLM:61b8310d091047cb03df8318",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:37f62821a99d472126d5ed39",
"CLM:493d7447358e78cfcfa2807c"
] | [
"PMCID:PMC8890430",
"PMCID:PMC9988634",
"PMCID:PMC9514276"
] | [
"SPAN:57ca7539b25bcdb16907905a",
"SPAN:2565648bd4a35a448a6e4baf",
"SPAN:4fb9f5007b2b9a8bf63a5657"
] | [
"ASC2:8ca7be18baa0c45d2b940b41",
"ASC2:f8f1fbb6580e8eceb0376552"
] | [
"HYP:DCH:fa4a5f7b8df2fe04df0a1587",
"HYP:DCH:f9347e0ec6b805440fd56d10"
] | {"qa_id":"QA:41259555d7c9e6836c483d8d","qa_group_id":"QAG:3b4e408257f7ac57cc1352c4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"PD-1 and PD-L1 co-expression predicted favorable prognosis in gast... |
QA:4313b68e53123c0ed6a0cdef | QAG:88eb5d533968843817d051f6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "This was consistent with several recent phase I/II single-armed studies in the 2021 ASCO annual meeting, which used ICI plus chemotherapy to treat cT3-4 or N+ gastric cancer patients and achieved >90% R0 resection rates, 0–25% CPR, and 22–42% MPR 26 – 31"? Return the o... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:99ca3c1d50780e2df717619a","quotes":["This was consistent with several recent phase I/II single-armed studies in t... | [
"CLM:99ca3c1d50780e2df717619a",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9810618"
] | [
"SPAN:a446c0a727a2f1b02b5cc994"
] | [] | [] | {"qa_id":"QA:4313b68e53123c0ed6a0cdef","qa_group_id":"QAG:88eb5d533968843817d051f6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"This was consistent with several recent phase I/II single-armed st... |
QA:438fce2a1183dcc7a0d93192 | QAG:2e0bd4005cca0ce49151bb30 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Here, we examined tumor specimens from 93 GI cancer patients who received ICBs, including anti-programmed cell death 1 (PD-1), anti-PD-L1, and anti-CTLA-4 antibodies"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fe9b556a72a15feb56f87aad","quotes":["Here, we examined tumor specimens from 93 GI cancer patients who were treate... | [
"CLM:fe9b556a72a15feb56f87aad",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7430454"
] | [
"SPAN:66a0550d58e23356da48bf14"
] | [] | [] | {"qa_id":"QA:438fce2a1183dcc7a0d93192","qa_group_id":"QAG:2e0bd4005cca0ce49151bb30","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Here, we examined tumor specimens from 93 GI cancer patients who r... |
QA:4516cf3f2bbc8102cb18315f | QAG:3cda1efdafffa6c40bc0c3a3 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Tumor mutational burden (TMB) was higher than the patients carrying MSI-H/dMMR tumors with B2M mutation than that in patients with wild-type B2M ( P = .026).The frame shift alteration occurring at the exonic microsatellite sties caused loss of function of B2M gene"? Re... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fb1c165d904d9f4cbbae36f1","quotes":["Alternations in the exonic microsatellite regions o... | [
"CLM:fb1c165d904d9f4cbbae36f1",
"CLM:030dc49284f8a34331af4784",
"CLM:0f10aec3cfff637781303dd8"
] | [
"PMCID:PMC10020813",
"PMCID:PMC7082319"
] | [
"SPAN:b76969049e626fa19c4dd06f",
"SPAN:f143174205fb4f358ec8245d"
] | [
"ASC2:faaf1ca3995bcc2605349f0e"
] | [] | {"qa_id":"QA:4516cf3f2bbc8102cb18315f","qa_group_id":"QAG:3cda1efdafffa6c40bc0c3a3","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Tumor mutational burden (TMB) was higher than the patients carryin... |
QA:47769e29828ff84ceadac324 | QAG:7c19b82373de4768e3162dab | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The results showed that compared with the SP regimen, the SOX regimen was associated with improved efficacy, survival and tolerance, and was then recommended as the first choice of treatment for non‐intestinal type gastric cancer"? Return the original wording with pape... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:af2f8a20351d59fe562a2c94","quotes":["The results showed that compared with the SP regimen, the SOX regimen was as... | [
"CLM:af2f8a20351d59fe562a2c94",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:8b55ebce41fcba6654d1bbf2"
] | [] | [] | {"qa_id":"QA:47769e29828ff84ceadac324","qa_group_id":"QAG:7c19b82373de4768e3162dab","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The results showed that compared with the SP regimen, the SOX regi... |
QA:47c6a729e0055f7a50873e17 | QAG:131ebc18add1a91537f60077 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "CR was achieved in four of five patients with low rectal cancer, including three with cCR and one with pCR"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7a5d5df732d3c4f7ef407a28","quotes":["CR was achieved in four of five patients with low rectal cancer, including t... | [
"CLM:7a5d5df732d3c4f7ef407a28",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:aefedec910f3dbe555520591"
] | [] | [] | {"qa_id":"QA:47c6a729e0055f7a50873e17","qa_group_id":"QAG:131ebc18add1a91537f60077","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"CR was achieved in four of five patients with low rectal cancer, i... |
QA:485f133cbc586db8457350ed | QAG:7c0a3d8be4e205d6c5eb7c7b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Between January 2016 and October 2022, 3200 patients received palliative chemotherapy for metastatic gastric cancer at Samsung Medical Center"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7d574c42ff98946ebc9ebfde","quotes":["Between January 2016 and October 2022, 3200 patients received palliative che... | [
"CLM:7d574c42ff98946ebc9ebfde",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10669208"
] | [
"SPAN:f401a12dd1329d1111fdd729"
] | [] | [] | {"qa_id":"QA:485f133cbc586db8457350ed","qa_group_id":"QAG:7c0a3d8be4e205d6c5eb7c7b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Between January 2016 and October 2022, 3200 patients received pall... |
QA:48da875f3c96b9e46626e670 | QAG:df378810180ff63a31ab8c70 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Design: In total, 63 patients with advanced gastric cancer treated with ICB were included in the study"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Cl... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:862061eadcf9176381d9b157","quotes":["Design: In total, 63 patients with advanced gastric cancer treated with ICB ... | [
"CLM:862061eadcf9176381d9b157",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:d885b6865f6f8794f4768703"
] | [] | [] | {"qa_id":"QA:48da875f3c96b9e46626e670","qa_group_id":"QAG:df378810180ff63a31ab8c70","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Design: In total, 63 patients with advanced gastric cancer treated... |
QA:4c9881a2913720cc447669f2 | QAG:a49b933b025ce2ae0b6c5047 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Even though MSI-H is a good predictor of responses, patients with advanced MSI-H gastric cancer received only 47–57% ORR from ICI monotherapy 33 and 55% ORR from ICI plus chemotherapy in CheckMate 649 34"? Return the original wording with paper, Claim, and Evidence Spa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:cacbba5dd0986a5d461ffead","quotes":["Even though MSI-H is a goo... | [
"CLM:cacbba5dd0986a5d461ffead",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:029b26bc41b64f28748169a4",
"CLM:91ed29d5543c0e4194721a87"
] | [
"PMCID:PMC9810618",
"PMCID:PMC9988634",
"PMCID:PMC8201030"
] | [
"SPAN:669d297855e0eef191d42a68",
"SPAN:3c3ff17dabcadb323a410fec",
"SPAN:cbc28044869692d9c2bb8065"
] | [
"ASC2:c09417c496d56e4b77837500",
"ASC2:6f31ad029ee90e9e9ec95d92"
] | [
"HYP:DCH:51e7267bffc7f3ffe9aac8e8"
] | {"qa_id":"QA:4c9881a2913720cc447669f2","qa_group_id":"QAG:a49b933b025ce2ae0b6c5047","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Even though MSI-H is a good predictor of responses, patients with ... |
QA:4fa8cbf405576348ebe05e14 | QAG:92c1ae684fcc8eb37a33c75e | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9033407? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC9033407","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC9033407"
] | [] | [] | [] | {"qa_id":"QA:4fa8cbf405576348ebe05e14","qa_group_id":"QAG:92c1ae684fcc8eb37a33c75e","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC9033407... |
QA:4fee48f1ababc29128713a81 | QAG:5663432c067908935cfd80d2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4 achieved progressive response (PR), resulting in an ORR of 55.6%, with good safety"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ret... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a88c83d812242126a3e9e45f","quotes":["Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4 achieved ... | [
"CLM:a88c83d812242126a3e9e45f",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:1890284dd4f876e30e4fc4d2"
] | [] | [] | {"qa_id":"QA:4fee48f1ababc29128713a81","qa_group_id":"QAG:5663432c067908935cfd80d2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4... |
QA:508cf9d26c240e41ef35f43e | QAG:3d190d07467f43782810d1eb | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "pCR was achieved in two of five patients with non-liver metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c00bbe3c7e936b6616fb613f","quotes":["All four patients with liver metastatic lesions from colon cancer reached CR... | [
"CLM:c00bbe3c7e936b6616fb613f",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:68446dc2c8ab44a32529d5cf"
] | [] | [] | {"qa_id":"QA:508cf9d26c240e41ef35f43e","qa_group_id":"QAG:3d190d07467f43782810d1eb","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"pCR was achieved in two of five patients with non-liver metastatic... |
QA:508ec64a5f1b93ae3970cc51 | QAG:f8569251269aad58268461dd | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The phase II multicenter C008 study showed that Disitamab vedotin used in advanced gastric cancer patients with HER2 positive expression (IHC 2+ or 3+) who had previously received ≥2 lines of therapy achieved an ORR of 24.4% and a median OS of 7.6 months"? Return the o... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:144e6c0982ff7494078b3f27","quotes":["The phase II multicenter C008 study showed that Disitamab vedotin used in ad... | [
"CLM:144e6c0982ff7494078b3f27",
"CLM:06d7a8039e910d5ad18fe47c"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:5231bf8330376182bcfded83"
] | [] | [] | {"qa_id":"QA:508ec64a5f1b93ae3970cc51","qa_group_id":"QAG:f8569251269aad58268461dd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The phase II multicenter C008 study showed that Disitamab vedotin ... |
QA:51337a9e0c2cee5dbe189996 | QAG:068010811c4e844c47c856de | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "We performed this study among 36 initially surgical resected difficult dMMR/MSI-H gastrointestinal malignancies such gastric cancer, duodenal cancer and colorectal cancer patients who received preoperative PD-1 blockade immunotherapy followed by surgery in order to inv... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:37f62821a99d472126d5ed39","quotes":["We performed this study among 36 initially surgical... | [
"CLM:37f62821a99d472126d5ed39",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:e49fa7ed81184fc679bd847f"
] | [
"PMCID:PMC9988634",
"PMCID:PMC7082319"
] | [
"SPAN:2565648bd4a35a448a6e4baf",
"SPAN:8a1076f3de5e40d2c863ee43"
] | [
"ASC2:726e60b809b0fe3479014d94"
] | [
"HYP:DCH:4094f6c34a53dd91901b0455"
] | {"qa_id":"QA:51337a9e0c2cee5dbe189996","qa_group_id":"QAG:068010811c4e844c47c856de","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"We performed this study among 36 initially surgical resected diffi... |
QA:524d5ed21759e42a6c8b8c52 | QAG:e749fde55f57bb8f1af1b3b2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "2‐positive gastric cancer patients who had failed standard treatment received Chimeric antigen receptor (CAR)‐T cell therapy and achieved an ORR of 57.1%"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements:... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:70d5173bfc30049e694f505c","quotes":["In a phase I study initiated by researchers, 28 Claudin18.2‐positive gastric... | [
"CLM:70d5173bfc30049e694f505c",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:09975a8fd318610f6c22bd8d"
] | [] | [] | {"qa_id":"QA:524d5ed21759e42a6c8b8c52","qa_group_id":"QAG:e749fde55f57bb8f1af1b3b2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"2‐positive gastric cancer patients who had failed standard treatme... |
QA:52ddcdd3e3599664873285c5 | QAG:3fb951e8d704d699c6dc2e2b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Regarding the utility of postoperative abdominal lavage in curative surgery for gastric cancer, findings from the 2021 EXPEL study indicate that postoperative abdominal lavage following standard D2 surgery did not improve the risk of peritoneal recurrence (7.9% vs. 6.6... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8f109ec60274fd13fa12fd53","quotes":["Regarding the utility of postoperative abdominal lavage in curative surgery ... | [
"CLM:8f109ec60274fd13fa12fd53",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:1d699a3d01b9ea1938457c0b"
] | [] | [] | {"qa_id":"QA:52ddcdd3e3599664873285c5","qa_group_id":"QAG:3fb951e8d704d699c6dc2e2b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Regarding the utility of postoperative abdominal lavage in curativ... |
QA:540d8f4f0c9b2bfbf51d098c | QAG:e57b340d838ff5b0be46ceb6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In June 2021, China NMPA conditionally approved Disitamab vedotin for HER2‐positive expressing advanced or metastatic gastric cancer (including EGJ adenocarcinoma) patients who had previously received ≥2 lines of therapy"? Return the original wording with paper, Claim,... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:09c2c57fe8646d298ad5a47f","quotes":["In June 2021, China NMPA conditionally approved Disitamab vedotin for HER2‐p... | [
"CLM:09c2c57fe8646d298ad5a47f",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:9acb6845c7a19e369985eb23"
] | [] | [] | {"qa_id":"QA:540d8f4f0c9b2bfbf51d098c","qa_group_id":"QAG:e57b340d838ff5b0be46ceb6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In June 2021, China NMPA conditionally approved Disitamab vedotin ... |
QA:56fb719b1ee122b13c5a9d00 | QAG:8f9433c97c3a315790b9ed2a | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "For patients with resectable advanced gastric cancer, it has been reported that preventive para‐aortic lymph node dissection was not associated with improved long‐term survival of these patients , and the value of therapeutic para‐aortic lymph node dissection is still ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9b074b4c794c926c6c612f83","quotes":["For patients with resectable advanced gastric cancer, it has been reported t... | [
"CLM:9b074b4c794c926c6c612f83",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:0c0b44d25364354efe4062eb"
] | [] | [] | {"qa_id":"QA:56fb719b1ee122b13c5a9d00","qa_group_id":"QAG:8f9433c97c3a315790b9ed2a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"For patients with resectable advanced gastric cancer, it has been ... |
QA:570901a64fd95b7f789eac48 | QAG:f2ff0a0cd48b1faa7f27cccc | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The SMC cohort was from a single‐center, phase 2 trial, in which 61 patients with metastatic gastric cancer (mGC) received pembrolizumab monotherapy ( ClinicalTrials.gov , NCT#02589496)"? Return the original wording with paper, Claim, and Evidence Span references.
Int... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7349255cfbb4014bf4c3c093","quotes":["The SMC cohort was from a single‐center, phase 2 trial, in which 61 patients... | [
"CLM:7349255cfbb4014bf4c3c093",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10920992"
] | [
"SPAN:0b465f9208d2cfa35f176f42"
] | [] | [] | {"qa_id":"QA:570901a64fd95b7f789eac48","qa_group_id":"QAG:f2ff0a0cd48b1faa7f27cccc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The SMC cohort was from a single‐center, phase 2 trial, in which 6... |
QA:57538bc317d1f52259b3168a | QAG:d3e817fd0f5e76b51a4391e9 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8569350? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC8569350","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC8569350"
] | [] | [] | [] | {"qa_id":"QA:57538bc317d1f52259b3168a","qa_group_id":"QAG:d3e817fd0f5e76b51a4391e9","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8569350... |
QA:576401ea061257446b4e80f3 | QAG:d60a9f3171424b94923ee0e5 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "A retrospective study showed that concurrent chemoradiotherapy in gastric cancer patients with local recurrence at the anastomic site or regional lymph nodes was associated with an ORR of 61.9% and mOS of 35 months"? Return the original wording with paper, Claim, and E... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:2bbe3dc5426f8bc9b9587cce","quotes":["A retrospective study showed that concurrent chemoradiotherapy in gastric ca... | [
"CLM:2bbe3dc5426f8bc9b9587cce",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:193ab7233d0ad132877b7bcd"
] | [] | [] | {"qa_id":"QA:576401ea061257446b4e80f3","qa_group_id":"QAG:d60a9f3171424b94923ee0e5","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"A retrospective study showed that concurrent chemoradiotherapy in ... |
QA:5c02631ea94b6c62dbeae5cb | QAG:53e7fe161ee6d39dd0645653 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "All four patients with liver metastasis from colon cancer achieved CR, including three pCR and one cCR. pCR was achieved in two of five patients with non-liver metastases from colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span referenc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c7d9d6a04134e20fec86aee6","quotes":["All four patients with liver metastasis from colon cancer achieved CR, inclu... | [
"CLM:c7d9d6a04134e20fec86aee6",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:6f4dcbaf990fab8d95140fdd"
] | [] | [] | {"qa_id":"QA:5c02631ea94b6c62dbeae5cb","qa_group_id":"QAG:53e7fe161ee6d39dd0645653","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"All four patients with liver metastasis from colon cancer achieved... |
QA:5ed351c7933d210c736274f8 | QAG:6162e223d5f2640c36aa9a9d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The dMMR/MSI-H status is a well-established prognostic factor for prolonged survival in stage II-III CRC patients, and a potential predictive marker for the lack of benefit from adjuvant fluoropyrimidine monotherapy in stage II disease"? Return the original wording wit... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:91ed29d5543c0e4194721a87","quotes":["The dMMR/MSI-H status is a well-established prognos... | [
"CLM:91ed29d5543c0e4194721a87",
"CLM:030dc49284f8a34331af4784",
"CLM:029b26bc41b64f28748169a4"
] | [
"PMCID:PMC8201030",
"PMCID:PMC9988634"
] | [
"SPAN:cbc28044869692d9c2bb8065",
"SPAN:3c3ff17dabcadb323a410fec"
] | [
"ASC2:f2d915a118e77a5c47822bd2"
] | [
"HYP:DCH:3bfc45f52d5682b866865af3"
] | {"qa_id":"QA:5ed351c7933d210c736274f8","qa_group_id":"QAG:6162e223d5f2640c36aa9a9d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The dMMR/MSI-H status is a well-established prognostic factor for ... |
QA:62787281488bf892ca8540b8 | QAG:1b9be8b6472de02322c60c78 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8748045? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiable... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC8748045","verdict":"no_released_traceable_claim","reason":"No ... | [] | [
"PMCID:PMC8748045"
] | [] | [] | [] | {"qa_id":"QA:62787281488bf892ca8540b8","qa_group_id":"QAG:1b9be8b6472de02322c60c78","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC8748045... |
QA:68d36708bf70be37b3367874 | QAG:9883776ff5547f35e018b9fc | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In a previous study on patients with metastatic gastric cancer treated with pembrolizumab, circulating tumor DNA mutation load was slightly, albeit not significantly correlated with objective response and predicted PFS ( 12 )"? Return the original wording with paper, C... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d32ea0fd57b5e65dfdfd232e","quotes":["In a previous study on patients with metastatic gastric cancer treated with ... | [
"CLM:d32ea0fd57b5e65dfdfd232e",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:50a904360e56289c24d17cbb"
] | [] | [] | {"qa_id":"QA:68d36708bf70be37b3367874","qa_group_id":"QAG:9883776ff5547f35e018b9fc","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In a previous study on patients with metastatic gastric cancer tre... |
QA:691e2dd216539c49537ad845 | QAG:3dc990f7ccd9ce8b9e30ee9f | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "h ToGA trial showed that, compared with chemotherapy alone, trastuzumab combined with first‐line chemotherapy was associated with improved efficacy and survival in HER2‐overexpressed, treatment‐naïve, advanced or metastatic gastric cancer patients"? Return the original... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:72a2738682dd8da9251748a7","quotes":["The risks and benefits of treatment should be carefully weighed depending on... | [
"CLM:72a2738682dd8da9251748a7",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:4687bf75563056fcc76a0eb5"
] | [] | [] | {"qa_id":"QA:691e2dd216539c49537ad845","qa_group_id":"QAG:3dc990f7ccd9ce8b9e30ee9f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"h ToGA trial showed that, compared with chemotherapy alone, trastu... |
QA:6a937940cd67e320ba178dce | QAG:180dd3bbc1bdd927f1d9ba07 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Abstract Background While the efficacy of immune checkpoint inhibitors (ICIs) is increasingly recognized in advanced gastric cancer (aGC), overall survival (OS) has not been consistently improved across the different randomized controlled trials (RCTs)"? Return the ori... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:93856a1ed88cc30eca700d17","quotes":["Abstract Background While the efficacy of immune checkpoint inhibitors (ICIs... | [
"CLM:93856a1ed88cc30eca700d17",
"CLM:030dc49284f8a34331af4784"
] | [
"PMCID:PMC9660259"
] | [
"SPAN:af1e88ae984bdff111919519"
] | [] | [] | {"qa_id":"QA:6a937940cd67e320ba178dce","qa_group_id":"QAG:180dd3bbc1bdd927f1d9ba07","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Abstract Background While the efficacy of immune checkpoint inhibi... |
QA:6b2e560f9ce1370e93719b20 | QAG:507a045a2cf10a9f1d3c957d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The JCOG0405 study reported that 2 cycles of neoadjuvant chemotherapy with S‐1 and cisplatin followed by D2 gastrectomy with para‐aortic lymph node dissection for gastric cancer with extensive lymph node metastasis was associated with a curative rate of 64.7%, R0 resec... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:51bef1ca6b2071eeab7db22e","quotes":["The JCOG0405 study [ 234 ] reported that 2 cycles of neoadjuvant chemotherap... | [
"CLM:51bef1ca6b2071eeab7db22e",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:3d11f5d72b59fddce29f15b1"
] | [] | [] | {"qa_id":"QA:6b2e560f9ce1370e93719b20","qa_group_id":"QAG:507a045a2cf10a9f1d3c957d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The JCOG0405 study reported that 2 cycles of neoadjuvant chemother... |
QA:6cd2edea6103364098682c53 | QAG:b42a7495a3b2600abe7bc845 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In addition, during the same period, the PRODIGY study reported that for locally advanced gastric cancer staged as cT2/3N+M0 or cT4/NxM0, 3 cycles of neoadjuvant docetaxel plus oxaliplatin plus S‐1 (DOS) chemotherapy plus 8 cycles of postoperative S‐1 monotherapy, comp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:93dd826233ae2d60ad018f23","quotes":["In addition, during the same period, the PRODIGY study [ 96 ] reported that ... | [
"CLM:93dd826233ae2d60ad018f23",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:a8841f29705c9d8eec6f747c"
] | [] | [] | {"qa_id":"QA:6cd2edea6103364098682c53","qa_group_id":"QAG:b42a7495a3b2600abe7bc845","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In addition, during the same period, the PRODIGY study reported th... |
QA:6ef125247458ad2af320e9f6 | QAG:6019b79c8d6caadaf9e458a3 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Programmed death-1 ligand-1 (PDL1) expression was associated with the prognosis of patients with stage II/III gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:b4295cf2d40728a8cf4eebb1","quotes":["7. Tamura T, Ohira M, Tanaka H, Muguruma K, Toyokawa T, Kubo N, Sakurai K, A... | [
"CLM:b4295cf2d40728a8cf4eebb1",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC8890430"
] | [
"SPAN:758f648adf49c7dca15c5b4c"
] | [] | [] | {"qa_id":"QA:6ef125247458ad2af320e9f6","qa_group_id":"QAG:6019b79c8d6caadaf9e458a3","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Programmed death-1 ligand-1 (PDL1) expression was associated with ... |
QA:6f2ecab2d97b91766825e12c | QAG:59b4e5a240a04b13e97d9a53 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Type II indicates a local central, bowl‐shaped ulcer with distinct increased margins; Type III suggests an infiltrating ulcerative tumor with indistinct boundaries; and Type IV depicts a diffuse tumor characterized by poorly demarcated, infiltrative growth (local Borrm... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:75208a58713d253524099483","quotes":["The Borrmann classification consists of four subtypes: Type I represents a n... | [
"CLM:75208a58713d253524099483",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:6a3783f79873b5aafe712523"
] | [] | [] | {"qa_id":"QA:6f2ecab2d97b91766825e12c","qa_group_id":"QAG:59b4e5a240a04b13e97d9a53","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Type II indicates a local central, bowl‐shaped ulcer with distinct... |
QA:6f822a3a470a0efbd80bb4a9 | QAG:f0f2c1733606aa2da1630f3b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "pCR was achieved in two of five patients with non-liver metastases from colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evid... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:9c32bf62536206dfb68e119a","quotes":["All four patients with liver metastasis from colon cancer achieved CR, inclu... | [
"CLM:9c32bf62536206dfb68e119a",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:6f4dcbaf990fab8d95140fdd"
] | [] | [] | {"qa_id":"QA:6f822a3a470a0efbd80bb4a9","qa_group_id":"QAG:f0f2c1733606aa2da1630f3b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"pCR was achieved in two of five patients with non-liver metastases... |
QA:720f51af39b9bb0b8085e0d1 | QAG:b359e81d4f112fa4db6dc516 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In line with these findings, our results demonstrated that PD-L1 positive (CPS ≥ 1%) gastric cancer was associated with an improved survival outcome with nivolumab, confirming the predictive value of tumor PD-L1 expression"? Return the original wording with paper, Clai... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:801cc38bf41b8c1a8d1fb745","quotes":["In line with these findings, our results demonstrat... | [
"CLM:801cc38bf41b8c1a8d1fb745",
"CLM:020da5685d7d17cde8a85f67",
"CLM:a4511a0eddd9a759b82051ea"
] | [
"PMCID:PMC8994342",
"PMCID:PMC8890430"
] | [
"SPAN:e79541b11df15dfde69f7833",
"SPAN:9973704f3f923575420400ee"
] | [
"ASC2:79ba3bd4afaf48de0d2d8c3e"
] | [
"HYP:DCH:66772f20183a2e3dd7a4cd60"
] | {"qa_id":"QA:720f51af39b9bb0b8085e0d1","qa_group_id":"QAG:b359e81d4f112fa4db6dc516","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In line with these findings, our results demonstrated that PD-L1 p... |
QA:7767bfc5dfba56166bb1c6cc | QAG:3f7d5c5291a1e2eb3f2a54cd | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The present study aims to evaluate the clinical implications of TMB using a small and verified panel and established biomarkers (PD-L1 CPS, EBV, and MSI) to better characterize and select advanced gastric cancer patients who may benefit from immunotherapy"? Return the ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:00345af022967e4fba38c511","quotes":["The present study aimed to assess the clinical impl... | [
"CLM:00345af022967e4fba38c511",
"CLM:020da5685d7d17cde8a85f67",
"CLM:de6383b1f7f2f6d7129a8592",
"CLM:e49fa7ed81184fc679bd847f",
"CLM:6619ca97e51076bae9dd521f"
] | [
"PMCID:PMC7082319",
"PMCID:PMC8896035",
"PMCID:PMC8491424"
] | [
"SPAN:fa9a5f716ba02975b6d21b57",
"SPAN:fcb2d2b3a07b3111d1181c74",
"SPAN:8a1076f3de5e40d2c863ee43",
"SPAN:f3ffb145836ffa63e7412004"
] | [
"ASC2:3137f8ca7c2cda360386179a",
"ASC2:24eff0751e7180788c5c42c9"
] | [
"HYP:DCH:9ae840e71301ed4fae557ced"
] | {"qa_id":"QA:7767bfc5dfba56166bb1c6cc","qa_group_id":"QAG:3f7d5c5291a1e2eb3f2a54cd","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The present study aims to evaluate the clinical implications of TM... |
QA:7f8e8f4d0ad1cacc55d0e2dc | QAG:19ab6c5cf41366fb64895fe8 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Of the six patients with MSI gastric cancer, five achieved PR with a median PFS of 12 months and one was refractory to nivolumab with a PFS of 0.17 months"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:504812e5fee4bd4e6e7f8e47","quotes":["Of the six patients with M... | [
"CLM:504812e5fee4bd4e6e7f8e47",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:030dc49284f8a34331af4784"
] | [
"PMCID:PMC7082319",
"PMCID:PMC8460994",
"PMCID:PMC8608814"
] | [
"SPAN:77df0dee82ad371d8d3e530d",
"SPAN:18e05c2a545b035275c7a23f",
"SPAN:4031f6535a226497fad1dc87"
] | [
"ASC2:65973dab9e5a6c63da80454c",
"ASC2:cfc13848d425ecf5723993d3"
] | [
"HYP:DCH:0eca63c06ff4b03ecfe85f63",
"HYP:DCH:71ac1e990de313ab567e2fb6"
] | {"qa_id":"QA:7f8e8f4d0ad1cacc55d0e2dc","qa_group_id":"QAG:19ab6c5cf41366fb64895fe8","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Of the six patients with MSI gastric cancer, five achieved PR with... |
QA:802d27c4689de85945cc0f78 | QAG:091962cf31196074d7c77d23 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Lung cancer patients with EGFR mutations had significantly lower TMB values than those with wild‐type EGFR , and increased TMB was associated with dMMR in colorectal cancer (CRC)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:08443da1793a00c9b7f19a98","quotes":["Lung cancer patients with EGFR mutations had signif... | [
"CLM:08443da1793a00c9b7f19a98",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:fb1c165d904d9f4cbbae36f1"
] | [
"PMCID:PMC6712454",
"PMCID:PMC10020813"
] | [
"SPAN:d488427d3d218addc147001d",
"SPAN:b76969049e626fa19c4dd06f"
] | [
"ASC2:4d0b3de42cb0c7e7cc321f2b"
] | [] | {"qa_id":"QA:802d27c4689de85945cc0f78","qa_group_id":"QAG:091962cf31196074d7c77d23","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Lung cancer patients with EGFR mutations had significantly lower T... |
QA:82e8c01beb098ea1f9ddc26e | QAG:d5a268235e334f8dc81e9c76 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4 achieved progressive response (PR), resulting in an ORR of 55.6%, with good safety"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: ret... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:97c9b4b69451f17534922823","quotes":["Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4 achieved ... | [
"CLM:97c9b4b69451f17534922823",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:1890284dd4f876e30e4fc4d2"
] | [] | [] | {"qa_id":"QA:82e8c01beb098ea1f9ddc26e","qa_group_id":"QAG:d5a268235e334f8dc81e9c76","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Among the 9 patients with gastric cancer/EGJ), 1 achieved CR and 4... |
QA:85370cfc851d44a271ddaed6 | QAG:39ca4c8bd87bcb5a6d069c0f | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Of the four patients with EBV-positive gastric cancer, two achieved PR with a PFS of 7.2 and 12.7 months and two were refractory to pembrolizumab and nivolumab with a PFS of 1.4 and 0.3 months"? Return the original wording with paper, Claim, and Evidence Span reference... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:af3ff82d51071b1713778d02","quotes":["Of the four patients with EBV-positive gastric cancer, two achieved PR with ... | [
"CLM:af3ff82d51071b1713778d02",
"CLM:029b26bc41b64f28748169a4"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:f51d8cb41238ae0cdec0b5c9"
] | [] | [] | {"qa_id":"QA:85370cfc851d44a271ddaed6","qa_group_id":"QAG:39ca4c8bd87bcb5a6d069c0f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Of the four patients with EBV-positive gastric cancer, two achieve... |
QA:86644e23bb1004ec0f54dc47 | QAG:d4caef0b50ba4bd9a25eb6a6 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Results of the international multicenter CRITICS study showed that compared with adjuvant chemotherapy alone, adjuvant chemoradiotherapy did not improve survival for stage IB‐IVA resectable gastric cancer or EGJ cancer patients who received neoadjuvant epirubicin, cisp... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d0e388bd5b2dacae90c99daa","quotes":["Results of the international multicenter CRITICS study [ 106 ] showed that c... | [
"CLM:d0e388bd5b2dacae90c99daa",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:844a23ae9d1acd29f5c3b6d1"
] | [] | [] | {"qa_id":"QA:86644e23bb1004ec0f54dc47","qa_group_id":"QAG:d4caef0b50ba4bd9a25eb6a6","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Results of the international multicenter CRITICS study showed that... |
QA:886b9e3aeea3fb67f1698d8c | QAG:0214844e521fc66b7bac73e2 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "15 However, additional insights are still needed for an in-depth view of the burden of CNAs, including copy-number gain (CNgain) and/or CNloss, in GI cancer patients who received ICB treatments"? Return the original wording with paper, Claim, and Evidence Span referenc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c4f5b8556fa2bca1b1211e8e","quotes":["15 However, additional insights are still needed for an in-depth view of the... | [
"CLM:c4f5b8556fa2bca1b1211e8e",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7430454"
] | [
"SPAN:6fd35c4d5f71bedf49989f83"
] | [] | [] | {"qa_id":"QA:886b9e3aeea3fb67f1698d8c","qa_group_id":"QAG:0214844e521fc66b7bac73e2","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"15 However, additional insights are still needed for an in-depth v... |
QA:88eb83bd549f61461200caa0 | QAG:daff568e8b14ee2dbd08515a | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In the dMMR/MSI‐H gastric cancer subgroup of the KEYNOTE‐062 study, 14, 17, and 19 patients received pembrolizumab monotherapy, pembrolizumab combined with chemotherapy, and chemotherapy alone, respectively"? Return the original wording with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:8560bf48da2fdd1b2b400470","quotes":["In the dMMR/MSI‐H gastric cancer subgroup of the KEYNOTE‐062 study, 14, 17, ... | [
"CLM:8560bf48da2fdd1b2b400470",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:7f661b42875fb8125257cea6"
] | [] | [] | {"qa_id":"QA:88eb83bd549f61461200caa0","qa_group_id":"QAG:daff568e8b14ee2dbd08515a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In the dMMR/MSI‐H gastric cancer subgroup of the KEYNOTE‐062 study... |
QA:8b7162d640cb1b7f946ea420 | QAG:e8f74478396bb6120a4e7f45 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "showed that robustness of deep learning classifier to detect EBV and MSI in gastric cancer increased when trained on multicenter pooled cohorts 28"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:030dc49284f8a34331af4784","quotes":["In the recent report, Muti et al. showed that robus... | [
"CLM:030dc49284f8a34331af4784",
"CLM:020da5685d7d17cde8a85f67",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC8608814",
"PMCID:PMC8460994"
] | [
"SPAN:4031f6535a226497fad1dc87",
"SPAN:18e05c2a545b035275c7a23f"
] | [
"ASC2:65973dab9e5a6c63da80454c"
] | [
"HYP:DCH:67d8762cdab862f856deee3a"
] | {"qa_id":"QA:8b7162d640cb1b7f946ea420","qa_group_id":"QAG:e8f74478396bb6120a4e7f45","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"showed that robustness of deep learning classifier to detect EBV a... |
QA:8db7be5c6d7b9620fd7af5d4 | QAG:5d949229550d6e7efdb7bf36 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "CR was achieved in four of five patients with low rectal cancer, including three with cCR and one with pCR. cCR was achieved in seven of 36 cases, among which, six were selected for watch and wait strategy"? Return the original wording with paper, Claim, and Evidence S... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:22e4597b31b9068ef6c9e201","quotes":["CR was achieved in four of five patients with low rectal cancer, including t... | [
"CLM:22e4597b31b9068ef6c9e201",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:74d64f9633803e6d666dc3d5"
] | [] | [] | {"qa_id":"QA:8db7be5c6d7b9620fd7af5d4","qa_group_id":"QAG:5d949229550d6e7efdb7bf36","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"CR was achieved in four of five patients with low rectal cancer, i... |
QA:8dd5c61a6976a0d5e67d1fc4 | QAG:5d082a753995ec09475bfa6a | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Eight of 16 patients with locally advanced colon cancer achieved pCR"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references;... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:fc9d96f6984c6b8896461b62","quotes":["Eight of 16 patients with locally advanced colon cancer achieved pCR."],"cit... | [
"CLM:fc9d96f6984c6b8896461b62",
"CLM:030dc49284f8a34331af4784"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:b40ed9f0ff91292f3b76fd4b"
] | [] | [] | {"qa_id":"QA:8dd5c61a6976a0d5e67d1fc4","qa_group_id":"QAG:5d082a753995ec09475bfa6a","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Eight of 16 patients with locally advanced colon cancer achieved p... |
QA:8e17afd90420af306fffb278 | QAG:fe2665217c4d2851e402bb71 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "pCR was achieved in two of five patients with non-liver metastatic colorectal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6654c8a7502597f1d9c5b8c7","quotes":["All four patients with liver metastasis from colon cancer reached CR, includ... | [
"CLM:6654c8a7502597f1d9c5b8c7",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:a902225e40d4acdcaf399e04"
] | [] | [] | {"qa_id":"QA:8e17afd90420af306fffb278","qa_group_id":"QAG:fe2665217c4d2851e402bb71","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"pCR was achieved in two of five patients with non-liver metastatic... |
QA:9539e5d416e2ee0672f2fca3 | QAG:b26994fa02713808fedd9a53 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "A structural limitation to our analysis is the fact that the ground truth methods for microsatellite instability were developed in colorectal cancer, which could explain why microsatellite instability can be predicted in colorectal cancer with an even higher performanc... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:08fd960f22a3e10f0681a799","quotes":["A structural limitation to our analysis is the fact that the ground truth me... | [
"CLM:08fd960f22a3e10f0681a799",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC8460994"
] | [
"SPAN:09f095849c3bff38f0410e51"
] | [] | [] | {"qa_id":"QA:9539e5d416e2ee0672f2fca3","qa_group_id":"QAG:b26994fa02713808fedd9a53","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"A structural limitation to our analysis is the fact that the groun... |
QA:962a3a45f37dc66d48533851 | QAG:34d1f8cbdac7b3a6d71cf495 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "RESULTS Three patients with locally advanced gastric cancer achieved pathological complete response (pCR)"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper,... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f1a2fdfcd4339789302c6025","quotes":["RESULTS Three patients with locally advanced gastric cancer achieved patholo... | [
"CLM:f1a2fdfcd4339789302c6025",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:f3dd6f50b95bd808e86b6657"
] | [] | [] | {"qa_id":"QA:962a3a45f37dc66d48533851","qa_group_id":"QAG:34d1f8cbdac7b3a6d71cf495","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"RESULTS Three patients with locally advanced gastric cancer achiev... |
QA:96666ab0fc78cc9f37db6390 | QAG:8adb86fc300e729964120fec | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Among the 3 gastric cancer patients who had received second‐line treatment, with a median follow‐up time of 7.16 months, 1 achieved PR and had an ORR of 33.3%"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirem... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:262c9b7d5d056985b76505ef","quotes":["Among the 3 gastric cancer patients who had received second‐line treatment, ... | [
"CLM:262c9b7d5d056985b76505ef",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:71706d6a338d1092c3c1e72c"
] | [] | [] | {"qa_id":"QA:96666ab0fc78cc9f37db6390","qa_group_id":"QAG:8adb86fc300e729964120fec","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Among the 3 gastric cancer patients who had received second‐line t... |
QA:968d8ce1aa1844d6a9100ba4 | QAG:ddaf5482f9552166340dcc7f | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "8%) achieved radiological downstaging"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Claim, and Evidence Span references; assess the embedded target Cla... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:3c7799f4c3468f36f3153f68","quotes":["In 11 patients with cT4aN+ gastric cancer, 9 (81.8%) achieved radiological d... | [
"CLM:3c7799f4c3468f36f3153f68",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC9810618"
] | [
"SPAN:dfef933c8506a53403960e09"
] | [] | [] | {"qa_id":"QA:968d8ce1aa1844d6a9100ba4","qa_group_id":"QAG:ddaf5482f9552166340dcc7f","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"8%) achieved radiological downstaging\"? Return the original wordi... |
QA:97204750397d3d4f43240e56 | QAG:a29b8dd77dcd09a8bb7c4314 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Whole-slide immunostaining for CD3, CD4, CD8, FoxP3 and PD-1 were performed with tissue samples of colorectal and gastric cancer (N=24) and the tumor-positive TIL cell densities was correlated with the tumor’s mutational features"? Return the original wording with pape... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6619ca97e51076bae9dd521f","quotes":["Whole-slide immunostaining for CD3, CD4, CD8, FoxP3... | [
"CLM:6619ca97e51076bae9dd521f",
"CLM:00345af022967e4fba38c511",
"CLM:4008e6d923fed22b0792c822"
] | [
"PMCID:PMC8491424",
"PMCID:PMC9988634"
] | [
"SPAN:f3ffb145836ffa63e7412004",
"SPAN:05262d9a848532c11dadbe18",
"SPAN:3c3ff17dabcadb323a410fec"
] | [
"ASC2:2eb165a69b3375ffff5e554b"
] | [] | {"qa_id":"QA:97204750397d3d4f43240e56","qa_group_id":"QAG:a29b8dd77dcd09a8bb7c4314","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Whole-slide immunostaining for CD3, CD4, CD8, FoxP3 and PD-1 were ... |
QA:99e47a1e7fe177c5999393c8 | QAG:6cf7414c2b8c6a799c484469 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In GC/GEJC, none of the therapeutic regimens achieved the threshold value score or grade even when the PD-L1 combined positive score (CPS) was ≥1. PD-L1 inhibitor monotherapy or in combination with CT did not reach the threshold in CRC, but the PD-1 inhibitor pembroliz... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:88bd2f3a71633f2c589dee1e","quotes":["In GC/GEJC, none of the therapeutic regimens achiev... | [
"CLM:88bd2f3a71633f2c589dee1e",
"CLM:0451c9b24139be1f5194d65a",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10160363",
"PMCID:PMC7082319"
] | [
"SPAN:555320ad60e9f047d76bf14f",
"SPAN:fa9a5f716ba02975b6d21b57"
] | [
"ASC2:5f8c624967af83362ac681ee"
] | [
"HYP:DCH:50824679a29e6b32fea91673"
] | {"qa_id":"QA:99e47a1e7fe177c5999393c8","qa_group_id":"QAG:6cf7414c2b8c6a799c484469","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In GC/GEJC, none of the therapeutic regimens achieved the threshol... |
QA:9a5efc9557a39e332ef0af34 | QAG:482385dcc696e713066fbb0d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Patients and Methods The cohort consisted of 248 patients diagnosed with gastric cancer who were hospitalized and received radical gastrectomy"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:367079b1fd137de3fc296255","quotes":["Patients and Methods The cohort consisted of 248 patients diagnosed with gas... | [
"CLM:367079b1fd137de3fc296255",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC9514276"
] | [
"SPAN:6871aa04c51fa54cebf2161a"
] | [] | [] | {"qa_id":"QA:9a5efc9557a39e332ef0af34","qa_group_id":"QAG:482385dcc696e713066fbb0d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Patients and Methods The cohort consisted of 248 patients diagnose... |
QA:9a99734914f6eb2a6082c294 | QAG:e5a411cf2b484a8ae1945eee | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In colorectal cancer cells, PTEN silencing increased PD-L1 protein expression while had no effects on PD-L1 mRNA, indicating that PTEN loss might influence PD-L1 protein stabilization"? Return the original wording with paper, Claim, and Evidence Span references.
Integ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification","cross_paper_provenance"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:493d7447358e78cfcfa2807c","quotes":["In colorectal cancer cells, PTEN silencing increase... | [
"CLM:493d7447358e78cfcfa2807c",
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:801cc38bf41b8c1a8d1fb745"
] | [
"PMCID:PMC9514276",
"PMCID:PMC8994342"
] | [
"SPAN:4fb9f5007b2b9a8bf63a5657",
"SPAN:e79541b11df15dfde69f7833"
] | [
"ASC2:f6605655bad8e74ac2a34a17"
] | [
"HYP:DCH:32b93dbc934b424af3de1ce7"
] | {"qa_id":"QA:9a99734914f6eb2a6082c294","qa_group_id":"QAG:e5a411cf2b484a8ae1945eee","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In colorectal cancer cells, PTEN silencing increased PD-L1 protein... |
QA:9aa8dd91ee280abacb251185 | QAG:6db30d0b1d00b2207d4e9039 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "It should only be considered cautiously in patients who have not received PD‐1/PD‐L1 monoclonal antibody therapy in the first and second lines after evaluating the patient's physical condition, potential risk of hyperprogression, and adverse reactions"? Return the orig... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0ca1bc5a12cf1e59cb7b271a","quotes":["It should only be considered cautiously in patients who have not received PD... | [
"CLM:0ca1bc5a12cf1e59cb7b271a",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:0aebde3e0736ab23383ee30a",
"SPAN:356761cc7e3e9905f8937f89"
] | [] | [] | {"qa_id":"QA:9aa8dd91ee280abacb251185","qa_group_id":"QAG:6db30d0b1d00b2207d4e9039","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"It should only be considered cautiously in patients who have not r... |
QA:a06941102c7bdda67ed6b329 | QAG:c99243597c4decb9bfa3f612 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Recently, immune checkpoint inhibitors (ICIs) achieved superior outcomes to placebo in the third-line treatment for advanced gastric cancer in phase III randomized controlled trials 7"? Return the original wording with paper, Claim, and Evidence Span references.
Integ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:d5243d562e24b9a1e0053613","quotes":["Recently, immune checkpoint inhibitors (ICIs) achieved superior outcomes to ... | [
"CLM:d5243d562e24b9a1e0053613",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9810618"
] | [
"SPAN:4cbbe2ab32c9edfcf7602441"
] | [] | [] | {"qa_id":"QA:a06941102c7bdda67ed6b329","qa_group_id":"QAG:c99243597c4decb9bfa3f612","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Recently, immune checkpoint inhibitors (ICIs) achieved superior ou... |
QA:a19e034513be11a66c9d9e77 | QAG:a0d9d2c602d440c68aeaab4d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "PD-L1 expression was associated with massive lymphocyte infiltration and histology in gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting passage with paper, Clai... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:a4511a0eddd9a759b82051ea","quotes":["69. Li Z, Lai Y, Sun L, Zhang X, Liu R, Feng G, Zhou L, Jia L, Huang X, Kang... | [
"CLM:a4511a0eddd9a759b82051ea",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC8890430"
] | [
"SPAN:9973704f3f923575420400ee"
] | [] | [] | {"qa_id":"QA:a19e034513be11a66c9d9e77","qa_group_id":"QAG:a0d9d2c602d440c68aeaab4d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"PD-L1 expression was associated with massive lymphocyte infiltrati... |
QA:a838a5d1b758d1abba716d6b | QAG:ef603e6c433355272751ed11 | provenance_qa | paper_evidence_availability | provenance_qa | G001 | en | train | Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC10491970? Explicitly abstain if it does not.
Integrated provenance requirements: report evidence availability or insufficiency without inventing missing full text. Keep each subtask answer separately identifiabl... | {"answer_type":"integrated_provenance","embedded_answer_types":["paper_evidence_availability"],"exact_evidence_retrieval":null,"limited_evidence_retrieval":null,"paper_evidence_availability":{"answer_type":"explicit_evidence_abstention","paper_id":"PMCID:PMC10491970","verdict":"no_released_traceable_claim","reason":"No... | [] | [
"PMCID:PMC10491970"
] | [] | [] | [] | {"qa_id":"QA:a838a5d1b758d1abba716d6b","qa_group_id":"QAG:ef603e6c433355272751ed11","qa_family":"provenance_qa","subtask_type":"paper_evidence_availability","language":"en","cluster_id":"G001","question":"Does the current traceable evidence dataset contain a usable Claim and exact source span for paper PMCID:PMC1049197... |
QA:a8a1efbc8a824a3a15cdffca | QAG:33002ac72e019410eae4c674 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "2 Stromal scores was associated with T-stage/overall survival/subtypes/TMB of gastric cancer. a Compared to the early T-stage, the advanced T-stage is associated with a higher stromal score (p < 0.001). b Distribution of stromal scores of GC subtypes"? Return the origi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:7e1ec2d06d7aa3ccce17a1f1","quotes":["Fig. 2 Stromal scores are associated with T-stage/overall survival/subtypes/... | [
"CLM:7e1ec2d06d7aa3ccce17a1f1",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC7092673"
] | [
"SPAN:e4503540aa87bd8c5c1c4c5a"
] | [] | [] | {"qa_id":"QA:a8a1efbc8a824a3a15cdffca","qa_group_id":"QAG:33002ac72e019410eae4c674","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"2 Stromal scores was associated with T-stage/overall survival/subt... |
QA:ace13ec4083a11da6fe7764c | QAG:2b893aa0da0a30e2c5074578 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Training of a deep learning-based classifier to distinguish between patients with positive EBV status, those with microsatellite instability, and those with negative EBV and microsatellite instability status (double-negative gastric cancer) in a single classification s... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:00eb0bb1568a36713b5fdcb4","quotes":["Training of a deep learning-based classifier to distinguish between patients... | [
"CLM:00eb0bb1568a36713b5fdcb4",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC8460994"
] | [
"SPAN:18e05c2a545b035275c7a23f"
] | [] | [] | {"qa_id":"QA:ace13ec4083a11da6fe7764c","qa_group_id":"QAG:2b893aa0da0a30e2c5074578","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Training of a deep learning-based classifier to distinguish betwee... |
QA:ae4fa59a63cfc130c016661a | QAG:002b350a2e17bee3f71f2b36 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Tumor mutational burden determined by panel sequencing predicted survival after immunotherapy in patients with advanced gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact s... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:ccb4798eb47e3fb2d65014c5","quotes":["2018;36(7):633‐641. 14. Kim J, Kim B, Kang SY, et al. Tumor mutational burde... | [
"CLM:ccb4798eb47e3fb2d65014c5",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC10557860"
] | [
"SPAN:3323f4d124184860ec63d943"
] | [] | [] | {"qa_id":"QA:ae4fa59a63cfc130c016661a","qa_group_id":"QAG:002b350a2e17bee3f71f2b36","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Tumor mutational burden determined by panel sequencing predicted s... |
QA:b102a798950b938ede1f22f4 | QAG:67735510ce8429b5b92d9a41 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "The incidence of hypoNa in in gastrointestinal cancers is approximately 10% and was associated with poor survival in various cancers"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact sup... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:6e29074c716b2658d04e39da","quotes":["The incidence of hypoNa in in gastrointestinal cancers is approximately 10% ... | [
"CLM:6e29074c716b2658d04e39da",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC8994342"
] | [
"SPAN:5bb35a12b76ce0d14179f997"
] | [] | [] | {"qa_id":"QA:b102a798950b938ede1f22f4","qa_group_id":"QAG:67735510ce8429b5b92d9a41","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"The incidence of hypoNa in in gastrointestinal cancers is approxim... |
QA:b3b65831e2e141d8b073d834 | QAG:c021446d092c87a6ef2568f4 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "29 Thus, the rates of PD‐L1 AMP among Chinese patients with LUAD, breast cancer, and CRC was lower than those observed in this previous study"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the ... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:bc709ec9c8cb5fde721d34dd","quotes":["29 Thus, the rates of PD‐L1 AMP among Chinese patients with LUAD, breast can... | [
"CLM:bc709ec9c8cb5fde721d34dd",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC6712454"
] | [
"SPAN:4838243d0ea4cb68c81265fa"
] | [] | [] | {"qa_id":"QA:b3b65831e2e141d8b073d834","qa_group_id":"QAG:c021446d092c87a6ef2568f4","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"29 Thus, the rates of PD‐L1 AMP among Chinese patients with LUAD, ... |
QA:b558d364709801eb74630393 | QAG:1604a78f91771849a435eceb | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "In the JACCRO GC‐07 study , the investigators found that S‐1+docetaxel (oral S‐1 on days 1‐14 with 7 days of rest followed by 6 cycles of S‐1 combined with docetaxel on day 1 of each cycle, then 4 further cycles of S‐1 on days 1‐28 every 42 days) was associated with im... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:81079166a9f64a5bea1392aa","quotes":["In the JACCRO GC‐07 study [ 82 , 84 ], the investigators found that S‐1+doce... | [
"CLM:81079166a9f64a5bea1392aa",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:640f6356ece964044ca84ed4"
] | [] | [] | {"qa_id":"QA:b558d364709801eb74630393","qa_group_id":"QAG:1604a78f91771849a435eceb","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"In the JACCRO GC‐07 study , the investigators found that S‐1+docet... |
QA:b727cd1d027553320cf9bcbf | QAG:eb91c2ef1f8113d8845b3c1b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "However, a phase III study found that the addition of docetaxel to cisplatin and S‐1 did not improve the OS in chemotherapy‐naïve, unresectable or recurrent gastric cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated proven... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0451c9b24139be1f5194d65a","quotes":["However, a phase III study found that the addition of docetaxel to cisplatin... | [
"CLM:0451c9b24139be1f5194d65a",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10794017"
] | [
"SPAN:b829547c81235d83635cc920"
] | [] | [] | {"qa_id":"QA:b727cd1d027553320cf9bcbf","qa_group_id":"QAG:eb91c2ef1f8113d8845b3c1b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"However, a phase III study found that the addition of docetaxel to... |
QA:b8a11943f2f040252b601282 | QAG:657c1d0d2f1102f73705de06 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Next, we identified that the CNA burden index revealed decreased levels in DCB versus NDB patients receiving immunotherapy in the GI cohort, with AUCs of 0.712 (discovery, p=0.021), 0.864 (validation, p=0.001), and 0.775 (the combined GI cancer patients, p<0.0001) ( fi... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:f8f9df835c38ec85dacbbb2c","quotes":["Next, we identified that the CNA burden index revealed significantly decreas... | [
"CLM:f8f9df835c38ec85dacbbb2c",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC7430454"
] | [
"SPAN:6acd074d3abb05629f9dc349"
] | [] | [] | {"qa_id":"QA:b8a11943f2f040252b601282","qa_group_id":"QAG:657c1d0d2f1102f73705de06","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Next, we identified that the CNA burden index revealed decreased l... |
QA:ba4ea4c7e828bb475ae4a1ad | QAG:aad4f765a6c75dc6f87f8f2b | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "This is a retrospective cohort study of 118 patients with stage IV gastric cancer who received palliative chemotherapy and conversion surgery with a negative resection margin at Samsung Medical Center"? Return the original wording with paper, Claim, and Evidence Span r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:115ebcc9fd99c6cecea107c9","quotes":["This is a retrospective cohort study of 118 patients with stage IV gastric c... | [
"CLM:115ebcc9fd99c6cecea107c9",
"CLM:029b26bc41b64f28748169a4"
] | [
"PMCID:PMC10669208"
] | [
"SPAN:0875ac3e274141d29d06de43"
] | [] | [] | {"qa_id":"QA:ba4ea4c7e828bb475ae4a1ad","qa_group_id":"QAG:aad4f765a6c75dc6f87f8f2b","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"This is a retrospective cohort study of 118 patients with stage IV... |
QA:bb601cc1a4aca7e0e3e49816 | QAG:9350a9f949d8da8a90abcb5d | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "We also observed that the median TMB of EBV-positive gastric cancer cases was higher than that of EBV-negative group, although it did not reach statistical significance as previously described ( 12 )"? Return the original wording with paper, Claim, and Evidence Span re... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:c4f87fbfb0cbe70a3dbfc14e","quotes":["We also observed that the median TMB of EBV-positive gastric cancer cases wa... | [
"CLM:c4f87fbfb0cbe70a3dbfc14e",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC7082319"
] | [
"SPAN:3aca042400ff19473e152878"
] | [] | [] | {"qa_id":"QA:bb601cc1a4aca7e0e3e49816","qa_group_id":"QAG:9350a9f949d8da8a90abcb5d","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"We also observed that the median TMB of EBV-positive gastric cance... |
QA:bbc86a9d386418d26468e46e | QAG:7145b57968c43d01763b1864 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Studies were included that met the following criteria: 1) population: patients with EC, GC, gastroesophageal junction cancer (GEJC) and CRC; 2) intervention: PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy (CT); 3) control: placebo or CT; 4) outcom... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:020da5685d7d17cde8a85f67","quotes":["Studies were included that met the following criteria: 1) population: patien... | [
"CLM:020da5685d7d17cde8a85f67",
"CLM:00345af022967e4fba38c511"
] | [
"PMCID:PMC10160363"
] | [
"SPAN:12396bd3c8671c807108a2cb"
] | [] | [] | {"qa_id":"QA:bbc86a9d386418d26468e46e","qa_group_id":"QAG:7145b57968c43d01763b1864","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Studies were included that met the following criteria: 1) populati... |
QA:bdb81743447807c63a72e990 | QAG:80982d21aab7432a066737cf | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "Combination of AKT1 and CDH1 mutations predicted primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance requirements: return the exact supporting pa... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:feee8ba15e826bd016af7803","quotes":["41. Wang Z, Zhang Q, Qi C, Bai Y, Zhao F, Chen H, Li Z, Wang X, Chen M, Gong... | [
"CLM:feee8ba15e826bd016af7803",
"CLM:00eb0bb1568a36713b5fdcb4"
] | [
"PMCID:PMC9988634"
] | [
"SPAN:7c3ef364248d9078a267bd88"
] | [] | [] | {"qa_id":"QA:bdb81743447807c63a72e990","qa_group_id":"QAG:80982d21aab7432a066737cf","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"Combination of AKT1 and CDH1 mutations predicted primary resistanc... |
QA:bed58189a09e675610ff5bb5 | QAG:c5850ab731a000b602c28749 | provenance_qa | exact_evidence_retrieval | provenance_qa | G001 | en | train | Which exact source passage supports the statement "For EBV prediction, slightly higher AUROCs were achieved in diffuse-type than in intestinal-type gastric cancer, except for in the BERN and TUM cohorts ( figure 1B )"? Return the original wording with paper, Claim, and Evidence Span references.
Integrated provenance r... | {"answer_type":"integrated_provenance","embedded_answer_types":["exact_evidence_retrieval","claim_evidence_verification"],"exact_evidence_retrieval":{"answer_type":"exact_evidence_retrieval","claim_id":"CLM:0a909d849a63441b2c9c6e3b","quotes":["For EBV prediction, slightly higher AUROCs were achieved in diffuse-type tha... | [
"CLM:0a909d849a63441b2c9c6e3b",
"CLM:020da5685d7d17cde8a85f67"
] | [
"PMCID:PMC8460994"
] | [
"SPAN:809cee93a6dfb1d1fa2ceb3a"
] | [] | [] | {"qa_id":"QA:bed58189a09e675610ff5bb5","qa_group_id":"QAG:c5850ab731a000b602c28749","qa_family":"provenance_qa","subtask_type":"exact_evidence_retrieval","language":"en","cluster_id":"G001","question":"Which exact source passage supports the statement \"For EBV prediction, slightly higher AUROCs were achieved in diffus... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.